Gene · 50848
Papers3,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota-A Narrative Review. | Nutrients | 2022 | 35745251 | PubTator, text mining | PubMed |
Personalized Nutrition Using Microbial Metabolite Phenotype to Stratify Participants and Non-Invasive Host Exfoliomics Reveal the Effects of Flaxseed Lignan Supplementation in a Placebo-Controlled Crossover Trial. | Nutrients | 2022 | 35745107 | PubTator, text mining | PubMed |
| Differential Immune Checkpoint and Ig-like V-Type Receptor Profiles in COVID-19: Associations with Severity and Treatment. | J Clin Med | 2022 | 35743356 | PubTator, text mining | PubMed |
| Tracking the Molecular Scenarios for Tumorigenic Remodeling of Extracellular Matrix Based on Gene Expression Profiling in Equine Skin Neoplasia Models. | Int J Mol Sci | 2022 | 35742950 | PubTator, text mining | PubMed |
| Intestinal Barrier Dysfunction in Fatty Liver Disease: Roles of Microbiota, Mucosal Immune System, and Bile Acids. | Semin Liver Dis | 2022 | 35738255 | PubTator, text mining | PubMed |
| Nuclear pore complex acetylation regulates mRNA export and cell cycle commitment in budding yeast. | EMBO J | 2022 | 35735140 | PubTator, text mining | PubMed |
| L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression. | J Immunother Cancer | 2022 | 35728870 | PubTator, text mining | PubMed |
| Lactylation may be a Novel Posttranslational Modification in Inflammation in Neonatal Hypoxic-Ischemic Encephalopathy. | Front Pharmacol | 2022 | 35721121 | PubTator, text mining | PubMed |
| Research progress of gut microbiota in hepatocellular carcinoma. | J Clin Lab Anal | 2022 | 35719048 | PubTator, text mining | PubMed |
| Membrane Lipids in Epithelial Polarity: Sorting out the PIPs. | Front Cell Dev Biol | 2022 | 35712665 | PubTator, text mining | PubMed |
| Following Roux-en-Y gastric bypass surgery, serum ceramides demarcate patients that will fail to achieve normoglycemia and diabetes remission. | Med | 2022 | 35709767 | PubTator, text mining | PubMed |
| The protective effects of hyperoside on Ang II-mediated apoptosis of bEnd.3 cells and injury of blood-brain barrier model in vitro. | BMC Complement Med Ther | 2022 | 35698113 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| MicroRNAs in the Regulation of Endometrial Receptivity for Embryo Implantation. | Int J Mol Sci | 2022 | 35682889 | PubTator, text mining | PubMed |
| Inhibition of HDAC and Signal Transduction Pathways Induces Tight Junctions and Promotes Differentiation in p63-Positive Salivary Duct Adenocarcinoma. | Cancers (Basel) | 2022 | 35681564 | PubTator, text mining | PubMed |
| Reovirus Activated Cell Death Pathways. | Cells | 2022 | 35681452 | PubTator, text mining | PubMed |
| PROTACs: great opportunities for academia and industry (an update from 2020 to 2021). | Signal Transduct Target Ther | 2022 | 35680848 | PubTator, text mining | PubMed |
| MASTL is enriched in cancerous and pluripotent stem cells and influences OCT1/OCT4 levels. | iScience | 2022 | 35677646 | PubTator, text mining | PubMed |
| Low-Intensity Focused Ultrasound Technique in Glioblastoma Multiforme Treatment. | Front Oncol | 2022 | 35677164 | PubTator, text mining | PubMed |
| Comparative Analysis of Gene Expression Patterns for Oral Epithelial Cell Functions in Periodontitis. | Front Oral Health | 2022 | 35677025 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/50848/papers?page=44